Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE2345.0533.8 (+1.46 %)

PREV CLOSE ( ) 2311.25

OPEN PRICE ( ) 2335.00

BID PRICE (QTY) 2345.05 (6)

OFFER PRICE (QTY) 2349.00 (5)

VOLUME 5425

TODAY'S LOW / HIGH ( )2311.00 2375.00

52 WK LOW / HIGH ( ) 707.92620

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987

Management Info

Daulat Medhora - Chairman Fredun Medhora - Managing Director

Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE

NEWS

08Jun Fredun Pharmaceuticals informs about c
Pursuant to Regulation 30 read with sub para 15, Para A Part A Schedule..

19May Fredun Pharmaceuticals gains on launch
Fredun Pharmaceuticals is currently trading at Rs. 2344.50, up by 41.95..

18May Fredun Pharmaceuticals moves up on lau
Fredun Pharmaceuticals is currently trading at Rs. 2380.00, up by 13.55..

18May Fredun Pharmaceuticals launches Hormon
Fredun Pharmaceuticals has launched Hormone Range Products, its premium..

16May Fredun Pharmaceuticals launches cellul
Fredun Pharmaceuticals has launched ‘DAULCEL’, its premium wellness and..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	110.64	332.070000000001
Gross Profit	115.32	475.820000000001
Operating Profit	291.3	947.940000000001
Net Sales	2130.52	6391.21

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Kwality Pharma (BSE) 2498.25 (6.93%)	M.Cap ( in Cr)2592.23
Abbott India (BSE) 26250.00 (0.40%)	M.Cap ( in Cr)55811.29
Venus Remedies (BSE) 1682.35 (5.00%)	M.Cap ( in Cr)2248.80
Concord Biotech (BSE) 1345.00 (5.78%)	M.Cap ( in Cr)14069.31
Caplin Point Lab (BSE) 2329.80 (3.20%)	M.Cap ( in Cr)17748.73

Shareholding Pattern

	NON-INSTITUTION	51.94%
	PROMOTERS	44.17%
	FI/BANKS/INSURANCE	1.37%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

FREDUN PHARMACEUTICALS LTD.